Log In
Print
BCIQ
Print
Print this Print this
 

Eylea, aflibercept ophthalmic solution (VEGF Trap-Eye)

  Manage Alerts
Collapse Summary General Information
Company Regeneron Pharmaceuticals Inc.
DescriptionHuman fusion protein that binds all forms of VEGF-A and placental growth factor (PGF; PlGF)
Molecular Target Vascular endothelial growth factor A (VEGF-A) ; Placental growth factor (PGF) (PlGF)
Mechanism of ActionVascular endothelial growth factor A (VEGF-A) inhibitor
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today